BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 3:51:00 PM | Browse: 498 | Download: 572
Publication Name World Journal of Gastroenterology
Manuscript ID 6597
Country/Territory Italy
Received
2013-10-25 11:48
Peer-Review Started
2013-10-25 19:27
To Make the First Decision
2013-11-13 13:38
Return for Revision
2013-11-14 12:23
Revised
2013-11-29 01:27
Second Decision
2014-01-20 17:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-20 18:11
Articles in Press
2014-05-23 11:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-07 04:44
Typeset the Manuscript
2014-05-26 10:07
Publish the Manuscript Online
2014-06-16 16:19
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
Manuscript Source Invited Manuscript
All Author List Maria Caterina Pallotti, Margherita Nannini, Claudio Agostinelli, Simona Leoni, Valerio Di Scioscio, Anna Mandrioli, Cristian Lolli, Maristella Saponara, Stefano Pileri, Luigi Bolondi, Guido Biasco and Maria Abbondanza Pantaleo
Funding Agency and Grant Number
Corresponding author Maria Caterina Pallotti, MD, Department of Specialized, Experimental, and Diagnostic Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. mcaterinapallotti@gmail.com
Keywords Hepatic epithelioid hemangioendothelioma; Liver; Lenalidomide; Magnetic resonance; Abdominal ultrasound
Core Tip Hepatic epithelioid hemangioendothelioma (HEH) is a rare tumor. Currently, no standard medical treatment is indicated in unresectable disease. We describe the case of a patient with HEH who obtained stable disease after 40 mo of treatment with lenalidomide. Tolerance to treatment was very good. This report highlights the possibility of obtaining very long stable disease with an anti-angiogenesis drug. In recent years, the introduction of angiogenesis inhibitors has offered an interesting medical approach to this rare tumor.
Publish Date 2014-06-16 16:19
Citation Pallotti MC, Nannini M, Agostinelli C, Leoni S, Di Scioscio V, Mandrioli A, Lolli C, Saponara M, Pileri S, Bolondi L, Biasco G, Pantaleo MA. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma. World J Gastroenterol 2014; 20(22): 7049-7054
Url http://www.wjgnet.com/1007-9327/full/v20/i22/7049.htm
DOI 10.3748/wjg.v20.i22.7049
Full Article (PDF) WJG-20-7049.pdf
Full Article (Word) WJG-20-7049.doc
Manuscript File 6597-Review.doc
Answering Reviewers 6597-Answering reviewers.pdf
Copyright License Agreement 6597-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6597-Language certificate.pdf
Peer-review Report 6597-Peer review(s).pdf
Scientific Editor Work List 6597-Scientific editor work list.doc